SCHEDULE: Isaiah Tibbs Reports Stake in Cero Therapeutics
Beneficial Ownership Filing
Isaiah Tibbs has filed a Schedule 13G, reporting beneficial ownership of 4.63% of Cero Therapeutics Holdings, Inc. common stock as of June 30, 2026.
Summary
- Isaiah Tibbs has filed an amended Schedule 13G, reporting beneficial ownership of 2,089,000 shares of Cero Therapeutics Holdings, Inc. common stock.
- This ownership represents 4.63% of the class of securities.
- The filing indicates sole voting power and sole dispositive power over these shares.
- The date of the event requiring this filing was June 30, 2026.
- The filing is an amendment, indicating a previous filing or change in ownership.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral filing, primarily reporting a change in beneficial ownership without significant new strategic or financial information.
Positives
- Increased transparency regarding significant beneficial ownership in Cero Therapeutics Holdings, Inc.
Negatives
- No new financial or strategic information is provided in this filing.
Risks
- Potential for future changes in beneficial ownership that could impact stock price or control.
Future Outlook
No forward-looking statements or guidance are provided in this filing.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant individual shareholders, indicating a passive investment stake. This filing provides insight into who holds substantial portions of Cero Therapeutics, which can be relevant for understanding potential market influences.
Stakeholder Impact
- Shareholders: Increased awareness of significant ownership stakes, potentially influencing market perception.
- Management: Awareness of a substantial shareholder, which may be considered in strategic decision-making.
Next Steps
- Monitor future filings for any changes in beneficial ownership by Isaiah Tibbs or other significant shareholders.
Key Dates
| Date | Description |
|---|---|
| 06/30/2026 | Date of Event Which Requires Filing of this Statement |
| 08/11/2026 | Date of Certification and Signature |
Keywords
Cero Therapeutics Holdings, Schedule 13G, Beneficial Ownership, Common Stock, Isaiah Tibbs, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.